中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2017
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2017  >  33(1): 160-162

Immune tolerance after drug withdrawal in a patient with chronic hepatitis B receiving PEG- IFNα- 2a treatment

DOI: 10.3969/j.issn.1001-5256.2017.01.035

  • Department of Hepatology,Wuhai Hospital for Infectious Diseases

  • Published Date: 2017-01-20
    Abstract
    • FullText(HTML)
  • loading
    • References(6)
  • [1]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
    [2]PAN Y,WANG LN,SONG ZX,et al.Comparison of effects of entecavir and interferon therapy for HBe Ag-positive Chronic hepatitis B[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2016,10(4):392-395.(in Chinese)潘玉,王莉娜,宋正霞,等.恩替卡韦与干扰素治疗HBe Ag阳性慢性乙型肝炎的疗效[J/CD].中华实验和临床感染病杂志:电子版,2016,10(4):392-395.
    [3]CHEN XY,LIU YL.How patients with hepatitis B get really recovered[J].J Pract Hepatol,2016,19(3):257-260.(in Chinese)陈新月,柳雅立.慢性乙型肝炎患者如何获得临床治愈[J].实用肝脏病杂志,2016,19(3):257-260.
    [4]LI Q,ZHUO QB,HUANG YX,et al.Combination therapy and sequential therapy with interferons and nucleos(t)ide analogues against HBV[J].J Clin Hepatol,2015,31(4):495-499.(in Ghinese)李强,卓其斌,黄玉仙,等.干扰素与核苷和核苷酸类药物联合或序贯治疗慢性乙型肝炎方案的探讨[J].临床肝胆病杂志,2015,31(4):495-499.
    [5] WANG GL,MAO QG.A progress study on the treatment of chronic hepatitis B with interferon and nucleotide and nucleotide analogues in combination or sequential therapies[J].Med Inf,2014,27(1):460-462.(in Chinese)王国亮,毛乾国.干扰素与核苷(酸)类似物联合/序贯治疗慢性乙型肝炎研究进展[J].医学信息,2014,27(1):460-462.
    [6] DOU XG.Treatment strategies for patients with positive HBs Ag and normal ALT[EB/OL].(2015-10-31)[2016-07-11].http://www.ihepa.com:8088/pc/detail/14145?from=singlemessage&isappinstalled=1(in Chinese)窦晓光.HBs Ag阳性、ALT正常患者的处理策略[EB/OL].(2015-10-31)[2016-07-11].http://www.ihepa.com:8088/pc/detail/14145?from=singlemessage&isappinstalled=1
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1725) PDF downloads(415) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return